Ex Parte KRAUS - Page 78

          Appeal No. 2005-0841                                                        
          Application No. 08/230,083                                                  

          Is it                                                                       
               (1) the subject matter of original patent application                  
          claims 1, 3-5 and 7-11 or                                                   
               (2) the subject matter of original patent application                  
          claims 1, 3-5 and 7-11 and, on a limitation-by-limitation basis,            
          the territory falling between the scope of                                  
                    (a) original patent application claims 1, 3-5 and 7-11            
          and                                                                         
                    (b) original patent application claims 2 and 12.                  
          For the reasons which follow, we believe that it is (1) while the           
          majority believes it is (2).                                                
               In the context of recapture under 35 U.S.C. § 251, surrendered         
          subject matter has been determined by the Supreme Court, the                
          Federal Circuit, or the Court of Customs and Patent Appeals (CCPA)          
          to be either (1) the rejected claim deliberately canceled or                
          amended in an effort to overcome a prior art rejection (which               
          strongly suggests that the applicant admits that the scope of the           
          claim before the cancellation or amendment is unpatentable);16 or           
          (2) the argued claim minus the argued limitations when surrender            



               16   See Leggett v. Avery, 101 U.S. 256, 259-60 (1879); Dobson v. Lees,
          137 U.S. 258, 265-66 (1890); Byers, 230 F.2d at 455-56, 109 USPQ at 55-56; In re
          Willingham, 282 F.2d 353, 356-57, 127 USPQ 211, 215-16 (CCPA 1960); In re   
          Wesseler, 367 F.2d 838, 151 USPQ 339 (CCPA 1966); In re Richman, 409 F.2d 269,
          161 USPQ 359 (CCPA 1969); In re Wadlinger, 496 F.2d 1200, 1207-08, 181 USPQ 826,
          832 (CCPA 1974); Ball Corporation v. United States, 729 F.2d 1429, 1435-36, 221
          USPQ 289, 293-95 (Fed. Cir. 1984); Whittaker Corp. v. UNR Industries Inc., 911
          F.2d 709, 713, 15 USPQ2d 1742, 1745 (Fed. Cir. 1990); Mentor Corp. v. Coloplast,
          Inc., 998 F.2d 992, 995, 27 USPQ2d 1521, 1524 (Fed. Cir. 1993); and Clement,
          131 F.3d at 1468-70, 45 USPQ2d at 1163-65.                                  
                                        -78-                                          


Page:  Previous  71  72  73  74  75  76  77  78  79  80  81  82  83  84  85  Next 

Last modified: November 3, 2007